Rheumatology Research Group

Publications published since 2000 from OUS - Rheumatology Research Group

381 publications found

Publications 2021

1. Bianchi M, Kozyrev SV, Notarnicola A, Hultin Rosenberg L, Karlsson Å, Pucholt P, Rothwell S, Alexsson A, Sandling JK, Andersson H, Cooper RG, Padyukov L, Tjärnlund A, Dastmalchi M, ImmunoArray Development Consortium, The DISSECT consortium, Meadows JRS, Pyndt Diederichsen L, Molberg Ø, Chinoy H, Lamb J, Rönnblom L, Lindblad-Toh K, Lundberg IE (2021)
   Contribution of rare genetic variation to disease susceptibility in a large Scandinavian myositis cohort
   Arthritis Rheumatol (in press)
   DOI 10.1002/art.41929, PubMed 34279065
2. Buschulte K, Hoffmann-Vold AM, Dobrota RD, Höger P, Krause A, Kreuter M (2021)
   [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]
   Z Rheumatol
   DOI 10.1007/s00393-021-01067-3, PubMed 34505934
3. Didriksen H, Molberg Ø, Fretheim H, Gude E, Jordan S, Brunborg C, Palchevskiy V, Garen T, Midtvedt Ø, Andreassen AK, Distler O, Belperio J, Hoffmann-Vold AM (2021)
   Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
   Arthritis Rheumatol, 73 (7), 1277-1287
   DOI 10.1002/art.41665, PubMed 33497027
4. Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen AC, Karsdal MA, Herrick AL, Distler JHW, Allanore Y, Hoffmann-Vold AM, Siebuhr AS, Distler O (2021)
   Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study
   Lancet Rheumatol., 3 (3), E175-E184
   DOI 10.1016/S2665-9913(20)30385-4
5. Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E, EUSTAR collaborators (2021)
   Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
   Rheumatology (Oxford) (in press)
   DOI 10.1093/rheumatology/keab302, PubMed 33769468
6. Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM, SENSCIS trial investigators (2021)
   Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
   Lancet Respir Med, 9 (1), 96-106
   DOI 10.1016/S2213-2600(20)30330-1, PubMed 33412120
7. Hoffmann-Vold AM, Bendstrup E, Dimitroulas T, Hesselstrand R, Morais A, Peltomaa R, Smith V, Welling J, Vonk MC, Wuyts WA (2021)
   Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
   Rheumatology (Oxford) (in press)
   DOI 10.1093/rheumatology/keab154, PubMed 33587103
8. Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø (2021)
   Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
   BMJ Open, 11 (6), e048541
   DOI 10.1136/bmjopen-2020-048541, PubMed 34168032
9. Hoffmann-Vold AM, Kreuter M (2021)
   One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?
   Thorax (in press)
   DOI 10.1136/thoraxjnl-2021-217811, PubMed 34446525
10. Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O (2021)
    Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
    ERJ Open Res, 7 (1)
    DOI 10.1183/23120541.00235-2020, PubMed 33644224
11. Hoffmann-Vold AM, Volkmann ER (2021)
    Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
    J. Scleroderma Relat. Disord., 6 (1), 2397198319891282-43
    DOI 10.1177/2397198319891282
12. Holme SS, Kilian K, Eggesbø HB, Moen JM, Molberg Ø (2021)
    Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis
    Arthritis Res Ther, 23 (1), 18
    DOI 10.1186/s13075-020-02401-x, PubMed 33430923
13. Iudici M, Jarlborg M, Lauper K, Müller-Ladner U, Smith V, Allanore Y, Balbir-Gurman A, Doria A, Airò P, Walker UA, Riccieri V, Vonk MC, Gabrielli A, Hoffmann-Vold AM, Szücs G, Martin T, Distler O, Courvoisier DS, EUSTAR collaborators (2021)
    Representativeness of Systemic Sclerosis Patients in Interventional Randomized Trials: an analysis of the EUSTAR database
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keab437, PubMed 33989387
14. Kreuter M, Hoffmann-Vold AM, Bendstrup E (2021)
    Interstitial lung diseases: quo vadis?
    Lancet Respir Med (in press)
    DOI 10.1016/S2213-2600(21)00403-3, PubMed 34499873
15. Marstein HS, Godang K, Flatø B, Sjaastad I, Bollerslev J, Sanner H (2021)
    Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study
    Pediatr Rheumatol Online J, 19 (1), 56
    DOI 10.1186/s12969-021-00543-z, PubMed 33902632
16. Nyborg GA, Molberg Ø (2021)
    Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature
    Semin Arthritis Rheum, 51 (5), 1033-1044 (in press)
    DOI 10.1016/j.semarthrit.2021.07.012, PubMed 34416625
17. Panagopoulos P, Goules A, Hoffmann-Vold AM, Matteson EL, Tzioufas A (2021)
    Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
    Ther Adv Musculoskelet Dis, 13, 1759720X211037519
    DOI 10.1177/1759720X211037519, PubMed 34471427
18. Reid S, Hagberg N, Sandling JK, Alexsson A, Pucholt P, Sjöwall C, Lerang K, Jönsen A, Gunnarsson I, Syvänen AC, Troldborg AM, Voss A, Bengtsson AA, Molberg Ø, Jacobsen S, Svenungsson E, Rönnblom L, Leonard D (2021)
    Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus
    Ann Rheum Dis, 80 (9), 1183-1189
    DOI 10.1136/annrheumdis-2020-219727, PubMed 33766895
19. Sande NK, Bøyesen P, Aga AB, Hammer HB, Flatø B, Roth J, Lilleby V (2021)
    Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis
    RMD Open, 7 (2)
    DOI 10.1136/rmdopen-2021-001581, PubMed 33883255
20. Sikkeland LIB, Qiao SW, Ueland T, Myrdal O, Wyrożemski Ł, Aukrust P, Jahnsen FL, Sjåheim T, Kongerud J, Molberg Ø, Lund MB, Bækkevold ES (2021)
    Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-γ
    Eur Respir J, 57 (3)
    DOI 10.1183/13993003.00983-2020, PubMed 33154027
21. Skorpen CG, Salvesen KÅB, Palm Ø, Radtke M, Wallenius M (2021)
    Pregnancy complications in women with systemic lupus erythematosus
    Tidsskr Nor Laegeforen, 141 (8)
    DOI 10.4045/tidsskr.20.0596, PubMed 34047174
22. Solomon JJ, Swigris JJ, Kreuter M, Polke M, Aronson K, Hoffmann-Vold AM, Dellaripa PF (2021)
    The Attitudes and Practices of Physicians Caring for Patients with Rheumatoid Arthritis-Interstitial Lung Disease: An International Survey
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keab552, PubMed 34260687
23. Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium, the ImmunoArray consortium, Meadows JRS, Rantapää-Dahlqvist S, Mandl T et al. (2021)
    Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome
    Rheumatology (Oxford), 60 (2), 837-848
    DOI 10.1093/rheumatology/keaa367, PubMed 32889544
24. Tollisen A, Flatø B, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A (2021)
    Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis
    Arthritis Care Res (Hoboken), 73 (2), 221-231
    DOI 10.1002/acr.24113, PubMed 31758669
25. van Leeuwen NM, Boonstra M, Bakker JA, Grummels A, Jordan S, Liem S, Distler O, Hoffmann-Vold AM, Melsens K, Smith V, Truchetet ME, Scherer HU, Toes R, Huizinga TWJ, de Vries-Bouwstra JK (2021)
    Anti-centromere antibody levels and isotypes and the development of systemic sclerosis
    Arthritis Rheumatol (in press)
    DOI 10.1002/art.41814, PubMed 34042326
26. Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J, Lin Q, Xie X, Zheng K, Zhang W, Du G, Zhang G, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE (2021)
    The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
    Arthritis Res Ther, 23 (1), 212
    DOI 10.1186/s13075-021-02586-9, PubMed 34391465

Publications 2020

1. Benvenuti F, Zanatta E, Avouac J, Müller-Ladner U, Cozzi F, Hoffmann-Vold AM, Gabrielli A, Distler O, Matucci-Cerinic M, Allanore Y, Doria A (2020)
   The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients
   Expert Rev Clin Immunol, 16 (11), 1065-1074
   DOI 10.1080/1744666X.2021.1836962, PubMed 33076716
2. Berntsen KS, Raastad T, Marstein H, Kirkhus E, Merckoll E, Cumming KT, Flatø B, Sjaastad I, Sanner H (2020)
   Functional and Structural Adaptations of Skeletal Muscle in Long-Term Juvenile Dermatomyositis: A Controlled Cross-Sectional Study
   Arthritis Rheumatol, 72 (5), 837-848
   DOI 10.1002/art.41174, PubMed 31746550
3. Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM (2020)
   Predictors of progression in systemic sclerosis patients with interstitial lung disease
   Eur Respir J, 55 (5)
   DOI 10.1183/13993003.02026-2019, PubMed 32079645
4. Durheim MT, Hoffmann-Vold AM, Eagan TM, Hovden AO, Lund MB, Bjerke G, Birring SS, Jonassen TM, Johansen OE, Sjåheim T (2020)
   ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
   BMJ Open Respir Res, 7 (1)
   DOI 10.1136/bmjresp-2020-000598, PubMed 32576559
5. Fretheim H, Chung BK, Didriksen H, Bækkevold ES, Midtvedt Ø, Brunborg C, Holm K, Valeur J, Tennøe AH, Garen T, Midtvedt T, Trøseid M, Zarè H, Lund MB, Hov JR, Lundin KEA, Molberg Ø, Hoffmann-Vold AM (2020)
   Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
   PLoS One, 15 (5), e0232739
   DOI 10.1371/journal.pone.0232739, PubMed 32437393
6. Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Molberg Ø, Hoffmann-Vold AM (2020)
   Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
   Rheumatology (Oxford), 59 (10), 2920-2929
   DOI 10.1093/rheumatology/keaa026, PubMed 32097470
7. Frid P, Augdal TA, Larheim TA, Halbig J, Rypdal V, Songstad NT, Rosén A, Tylleskär KB, Berstad JR, Flatø B, Stoustrup P, Rosendahl K, Kirkhus E, Nordal E (2020)
   Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study
   Pediatr Rheumatol Online J, 18 (1), 75
   DOI 10.1186/s12969-020-00464-3, PubMed 32998740
8. Frid P, Baraniya D, Halbig J, Rypdal V, Songstad NT, Rosèn A, Berstad JR, Flatø B, Alakwaa F, Gil EG, Cetrelli L, Chen T, Al-Hebshi NN, Nordal E, Al-Haroni M (2020)
   Salivary Oral Microbiome of Children With Juvenile Idiopathic Arthritis: A Norwegian Cross-Sectional Study
   Front Cell Infect Microbiol, 10, 602239
   DOI 10.3389/fcimb.2020.602239, PubMed 33251163
9. Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz HI, Lovell DJ, Wolfs T, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok F, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, K Oliveira S, Cattalini M, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N et al. (2020)
   Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
   Arthritis Res Ther, 22 (1), 71
   DOI 10.1186/s13075-020-02167-2, PubMed 32264969
10. Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Kowal-Bielecka O, Riccardi A, Distler O, EUSTAR collaborators (2020)
    Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Ann Rheum Dis, 80 (2), 219-227
    DOI 10.1136/annrheumdis-2020-217455, PubMed 32988845
11. Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M (2020)
    The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease
    Respir Res, 21 (1), 197
    DOI 10.1186/s12931-020-01459-0, PubMed 32703199
12. Hoffmann-Vold AM, Fretheim H, Didriksen H, Molberg Ø (2020)
    The potential of fecal microbiota transplantation in systemic sclerosis
    Expert Rev Clin Immunol, 16 (2), 117-118
    DOI 10.1080/1744666X.2019.1707665, PubMed 31858856
13. Hoffmann-Vold AM, Fretheim H, Meier C, Maurer B (2020)
    Circulating biomarkers of systemic sclerosis - interstitial lung disease
    J. Scleroderma Relat. Disord., 5 (2_SUPPL 2_), 2397198319894851-47
    DOI 10.1177/2397198319894851
14. Hoffmann-Vold AM, Maher TM, Distler O (2020)
    European consensus statements for interstitial lung disease in systemic sclerosis Reply
    Lancet Rheumatol., 2 (6), E319-E320
15. Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellvi I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillen-Del-Castillo A, Hamid AM, Horvath R, Hughes M, Kreuter M, Moazedi-Fuerst F, Olas J, Paul S, Rotondo C et al. (2020)
    The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
    Lancet Rheumatol., 2 (2), E71-E83
    DOI 10.1016/S2665-9913(19)30144-4
16. Hoffmann-Vold AM, Molberg Ø (2020)
    Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis
    Curr Opin Rheumatol, 32 (6), 497-504
    DOI 10.1097/BOR.0000000000000741, PubMed 32890027
17. Holme SS, Moen JM, Kilian K, Eggesbø HB, Molberg Ø (2020)
    Impact of Paranasal Sinus Surgery in Granulomatosis With Polyangiitis: A Longitudinal Computed Tomography Study
    Laryngoscope, 130 (8), E460-E468
    DOI 10.1002/lary.28639, PubMed 32243590
18. Lemmers JMJ, Fretheim H, Knaapen HKA, van den Hoogen FHJ, Van Haren-Willems JHGM, Duijnhouwer AL, van Dijk AP, van den Ende CHM, Hoffmann-Vold AM, Vonk MC (2020)
    Selexipag treatment in patients with systemic sclerosis-associated pulmonary arterial hypertension in clinical practice, a case series
    J. Scleroderma Relat. Disord., 5 (3), 2397198320916082-NP11
    DOI 10.1177/2397198320916082
19. Malattia C, Ruperto N, Pederzoli S, Palmisani E, Pistorio A, Wouters C, Dolezalova P, Flato B, Garay S, Giancane G, Wells C, Douglass W, Brunner HI, De Benedetti F, Ravelli A, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) (2020)
    Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
    Arthritis Res Ther, 22 (1), 211
    DOI 10.1186/s13075-020-02303-y, PubMed 32912276
20. Marstein H, Schwartz T, Aaløkken TM, Lund MB, Flatø B, Sjaastad I, Sanner H (2020)
    Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease
    Rheumatology (Oxford), 59 (8), 1862-1870
    DOI 10.1093/rheumatology/kez531, PubMed 31740970
21. Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, Richeldi L, Hoffmann-Vold AM, Cottin V (2020)
    Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
    Adv Ther, 38 (2), 854-867
    DOI 10.1007/s12325-020-01578-6, PubMed 33315170
22. Ossum AM, Palm Ø, Cvancarova M, Bernklev T, Jahnsen J, Moum B, Høivik ML, IBSEN Study Group (2020)
    The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study)
    Inflamm Bowel Dis, 26 (1), 114-124
    DOI 10.1093/ibd/izz105, PubMed 31127829
23. Sandling JK, Pucholt P, Hultin Rosenberg L, Farias FHG, Kozyrev SV, Eloranta ML, Alexsson A, Bianchi M, Padyukov L, Bengtsson C, Jonsson R, Omdal R, Lie BA, Massarenti L, Steffensen R, Jakobsen MA, Lillevang ST, ImmunoArray Development Consortium and DISSECT consortium, Lerang K, Molberg Ø, Voss A, Troldborg A, Jacobsen S, Syvänen AC, Jönsen A et al. (2020)
    Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing
    Ann Rheum Dis, 80 (1), 109-117
    DOI 10.1136/annrheumdis-2020-218636, PubMed 33037003
24. Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL (2020)
    Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
    Ann Rheum Dis, 80 (2), 143-150
    DOI 10.1136/annrheumdis-2020-217230, PubMed 33037004
25. Tashbayev B, Garen T, Palm Ø, Chen X, Herlofson BB, Young A, Hove LH, Rykke M, Singh PB, Aqrawi LA, Utheim ØA, Utheim TP, Jensen JL (2020)
    Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study
    Sci Rep, 10 (1), 2063
    DOI 10.1038/s41598-020-59078-0, PubMed 32034249

Publications 2019

1. Aqrawi LA, Galtung HK, Guerreiro EM, Øvstebø R, Thiede B, Utheim TP, Chen X, Utheim ØA, Palm Ø, Skarstein K, Jensen JL (2019)
   Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers
   Arthritis Res Ther, 21 (1), 181
   DOI 10.1186/s13075-019-1961-4, PubMed 31366407
2. Barth Z, Schwartz T, Flatø B, Aaløkken TM, Koller A, Lund MB, Sjaastad I, Sanner H (2019)
   Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium to Longstanding Juvenile Dermatomyositis
   Arthritis Care Res (Hoboken), 71 (4), 492-497
   DOI 10.1002/acr.23687, PubMed 29953739
3. Berntsen KS, Edvardsen E, Hansen BH, Flatø B, Sjaastad I, Sanner H (2019)
   Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active/inactive disease
   Rheumatology (Oxford), 58 (3), 492-501
   DOI 10.1093/rheumatology/key342, PubMed 30508195
4. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
   Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
   Blood Press, 29 (2), 123-134
   DOI 10.1080/08037051.2019.1684817, PubMed 31718316
5. Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A et al. (2019)
   Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
   J Clin Med, 8 (11)
   DOI 10.3390/jcm8112013, PubMed 31752231
6. Chen X, Aqrawi LA, Utheim TP, Tashbayev B, Utheim ØA, Reppe S, Hove LH, Herlofson BB, Singh PB, Palm Ø, Galtung HK, Jensen JCL (2019)
   Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations
   Sci Rep, 9 (1), 7319
   DOI 10.1038/s41598-019-43714-5, PubMed 31086200
7. Christophersen A, Lund EG, Snir O, Solà E, Kanduri C, Dahal-Koirala S, Zühlke S, Molberg Ø, Utz PJ, Rohani-Pichavant M, Simard JF, Dekker CL, Lundin KEA, Sollid LM, Davis MM (2019)
   Distinct phenotype of CD4⁺ T cells driving celiac disease identified in multiple autoimmune conditions
   Nat Med, 25 (5), 734-737
   DOI 10.1038/s41591-019-0403-9, PubMed 30911136
8. Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, Bovis F, De Inocencio J, Demirkaya E, Flato B, Foell D, Garay SM, Lazăr C, Lovell DJ, Montobbio C, Miettunen P, Mihaylova D, Nielsen S, Orban I, Rumba-Rozenfelde I, Magalhães CS, Shafaie N, Susic G, Trachana M, Wulffraat N et al. (2019)
   Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
   Lancet Child Adolesc Health, 3 (4), 255-263
   DOI 10.1016/S2352-4642(19)30027-6, PubMed 30819662
9. Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM (2019)
   Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease
   Expert Rev Clin Immunol, 15 (10), 1009-1017
   DOI 10.1080/1744666X.2020.1668269, PubMed 31566449
10. Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V et al. (2019)
    Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
    Ann Rheum Dis, 78 (7), 979-987
    DOI 10.1136/annrheumdis-2018-214816, PubMed 30967395
11. Elhai M, Hoffmann-Vold AM, Allanore Y (2019)
    Reply
    Arthritis Rheumatol, 71 (7), 1204-1206
    DOI 10.1002/art.40908, PubMed 31082000
12. Elhai M, Hoffmann-Vold AM, Avouac J, Pezet S, Cauvet A, Leblond A, Fretheim H, Garen T, Kuwana M, Molberg Ø, Allanore Y (2019)
    Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Arthritis Rheumatol, 71 (6), 972-982
    DOI 10.1002/art.40815, PubMed 30624031
13. Garen T, Lerang K, Hoffmann-Vold AM, Andersson H, Midtvedt Ø, Brunborg C, Kilian K, Gudbrandsson B, Gunnarsson R, Norby G, Chaudhary A, Thoen J, Forseth KØ, Fresjar K, Førre Ø, Haugen M, Haga HJ, Gran JT, Gilboe IM, Molberg Ø, Palm Ø (2019)
    Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
    Rheumatology (Oxford), 58 (2), 313-320
    DOI 10.1093/rheumatology/key285, PubMed 30281089
14. Hoffmann-Vold AM, Didriksen H, Molberg Ø (2019)
    Reply
    Arthritis Rheumatol, 71 (4), 655-656
    DOI 10.1002/art.40816, PubMed 30663863
15. Hoffmann-Vold AM, Distler O, Murray B, Kowal-Bielecka O, Khanna D, Allanore Y, EUSTAR and SCTC collaborators (2019)
    Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
    RMD Open, 5 (1), e000826
    DOI 10.1136/rmdopen-2018-000826, PubMed 30997150
16. Hoffmann-Vold AM, Weigt SS, Saggar R, Palchevskiy V, Volkmann ER, Liang LL, Ross D, Ardehali A, Lynch JP, Belperio JA (2019)
    Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
    EBioMedicine, 50, 379-386
    DOI 10.1016/j.ebiom.2019.10.050, PubMed 31732480
17. Hokstad I, Deyab G, Wang Fagerland M, Lyberg T, Hjeltnes G, Førre Ø, Agewall S, Mollnes TE, Hollan I (2019)
    Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
    PLoS One, 14 (7), e0220079
    DOI 10.1371/journal.pone.0220079, PubMed 31335881
18. Kreuter M, Hoffmann-Vold AM (2019)
    New ways in the treatment of SSc-ILD: what makes sense?
    Pneumologe, 16 (5), 303-304
    DOI 10.1007/s10405-019-0269-z
19. López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A et al. (2019)
    GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
    Nat Commun, 10 (1), 4955
    DOI 10.1038/s41467-019-12760-y, PubMed 31672989
20. Reppe Moe SE, Molberg Ø, Strøm EH, Lerang K (2019)
    Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort
    Lupus, 28 (7), 818-825
    DOI 10.1177/0961203319847275, PubMed 31072277
21. Risum K, Edvardsen E, Godang K, Selvaag AM, Hansen BH, Molberg Ø, Bollerslev J, Holm I, Dagfinrud H, Sanner H (2019)
    Physical Fitness in Patients With Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis Diagnosed in the Era of Biologics: A Controlled Cross-Sectional Study
    Arthritis Care Res (Hoboken), 71 (12), 1611-1620
    DOI 10.1002/acr.23818, PubMed 30474929
22. Risum K, Edvardsen E, Selvaag AM, Dagfinrud H, Sanner H (2019)
    Measurement properties and performance of an eight-minute submaximal treadmill test in patients with juvenile idiopathic arthritis: a controlled study
    Pediatr Rheumatol Online J, 17 (1), 14
    DOI 10.1186/s12969-019-0316-7, PubMed 30961626
23. Singh PB, Young A, Homayouni A, Hove LH, Petrovski BÉ, Herlofson BB, Palm Ø, Rykke M, Jensen JL (2019)
    Distorted Taste and Impaired Oral Health in Patients with Sicca Complaints
    Nutrients, 11 (2)
    DOI 10.3390/nu11020264, PubMed 30682880
24. Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Midtvedt Ø, Garen T, Dalen H, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM (2019)
    Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
    ACR Open Rheumatol, 1 (4), 258-266
    DOI 10.1002/acr2.1037, PubMed 31777802
25. Tollisen A, Selvaag AM, Aasland A, Lerdal A, Flatø B (2019)
    Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis
    J Rheumatol, 46 (10), 1335-1344
    DOI 10.3899/jrheum.180948, PubMed 30877211
26. Volkmann ER, Hoffmann-Vold AM (2019)
    Gastrointestinal tract microbiota modifications in systemic sclerosis
    Eur J Rheumatol, 7 (Suppl 3), S228-S236
    DOI 10.5152/eurjrheum.2019.19103, PubMed 31922474
27. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM (2019)
    Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
    J Rheumatol, 46 (10), 1316-1325
    DOI 10.3899/jrheum.180441, PubMed 30770517
28. Witczak BN, Hetlevik SO, Sanner H, Barth Z, Schwartz T, Flatø B, Lilleby V, Sjaastad I (2019)
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study
    J Rheumatol, 46 (7), 739-747
    DOI 10.3899/jrheum.180526, PubMed 30877222

Publications 2018

1. Aqrawi LA, Chen X, Jensen JL, Morthen MK, Thiede B, Utheim ØA, Palm Ø, Tashbayev B, Utheim TP, Galtung HK (2018)
   Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome
   PLoS One, 13 (10), e0205762
   DOI 10.1371/journal.pone.0205762, PubMed 30312344
2. Aulie HA, Estensen ME, Selvaag AM, Lilleby V, Flatø B, Aakhus S (2018)
   Arterial properties in adults with long-lasting active juvenile idiopathic arthritis compared to healthy controls
   Pediatr Rheumatol Online J, 16 (1), 85
   DOI 10.1186/s12969-018-0302-5, PubMed 30594204
3. Barth Z, Witczak BN, Flatø B, Koller A, Sjaastad I, Sanner H (2018)
   Assessment of Microvascular Abnormalities by Nailfold Capillaroscopy in Juvenile Dermatomyositis After Medium- to Long-Term Followup
   Arthritis Care Res (Hoboken), 70 (5), 768-776
   DOI 10.1002/acr.23338, PubMed 28805016
4. Flato B, Rygg M, Nordal EB, Røisland M, Ødegård HB, Hoftun GB, Songstad NT, Consolaro A, Bovis F, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2018)
   The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
   Rheumatol Int, 38 (Suppl 1), 291-298
   DOI 10.1007/s00296-018-3963-y, PubMed 29637327
5. Götestam Skorpen C, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Koksvik HSS, Jakobsen B, Wallenius M (2018)
   Women with systemic lupus erythematosus get pregnant more easily than women with rheumatoid arthritis
   Rheumatology (Oxford), 57 (6), 1072-1079
   DOI 10.1093/rheumatology/key049, PubMed 29554346
6. Guderud K, Mæhlen MT, Nordang GBN, Viken MK, Andreassen BK, Molberg Ø, Flåm ST, Lie BA (2018)
   Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis
   J Rheumatol, 45 (9), 1211-1219
   DOI 10.3899/jrheum.170769, PubMed 29858238
7. Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC et al. (2018)
   Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
   Ann Rheum Dis, 77 (4), 563-570
   DOI 10.1136/annrheumdis-2017-211912, PubMed 29306872
8. Hetlevik SO, Flatø B, Aaløkken TM, Lund MB, Reiseter S, Mynarek GK, Nordal E, Rygg M, Lilleby V (2018)
   Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease
   J Rheumatol, 46 (1), 93-100
   DOI 10.3899/jrheum.180019, PubMed 30068767
9. Hoffmann-Vold AM, Fretheim H, Midtvedt Ø, Kilian K, Angelshaug M, Chaudhary A, Gunnarsson R, Brunborg C, Garen T, Andreassen AK, Gude E, Molberg Ø (2018)
   Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
   Rheumatology (Oxford), 57 (3), 480-487
   DOI 10.1093/rheumatology/kex435, PubMed 29237073
10. Hoffmann-Vold AM, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK, Brunborg C, Palchevskiy V, Midtvedt Ø, Garen T, Aukrust P, Belperio JA, Molberg Ø (2018)
    CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
    Arthritis Rheumatol, 70 (10), 1644-1653
    DOI 10.1002/art.40534, PubMed 29687634
11. Hoffmann-Vold AM, Molberg Ø (2018)
    CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosis
    Arthritis Rheumatol (in press)
    DOI 10.1002/art.40740, PubMed 30281215
12. Hoffmann-Vold AM, Weigt SS, Palchevskiy V, Volkmann E, Saggar R, Li N, Midtvedt Ø, Lund MB, Garen T, Fishbein MC, Ardehali A, Ross DJ, Ueland T, Aukrust P, Lynch JP, Elashoff RM, Molberg Ø, Belperio JA (2018)
    Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
    PLoS One, 13 (11), e0206545
    DOI 10.1371/journal.pone.0206545, PubMed 30457999
13. Nesvold MB, Jensen JL, Hove LH, Singh PB, Young A, Palm Ø, Andersen LF, Carlsen MH, Iversen PO (2018)
    Dietary Intake, Body Composition, and Oral Health Parameters among Female Patients with Primary Sjögren's Syndrome
    Nutrients, 10 (7)
    DOI 10.3390/nu10070866, PubMed 29973575
14. Ossum AM, Palm Ø, Cvancarova M, Solberg IC, Vatn M, Moum B, Høivik ML, IBSEN study group (2018)
    Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study
    Scand J Gastroenterol, 53 (10-11), 1250-1256
    DOI 10.1080/00365521.2018.1518482, PubMed 30353756
15. Ossum AM, Palm Ø, Lunder AK, Cvancarova M, Banitalebi H, Negård A, Høie O, Henriksen M, Moum BA, Høivik ML, IBSEN Study Group (2018)
    Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study
    J Crohns Colitis, 12 (1), 96-104
    DOI 10.1093/ecco-jcc/jjx126, PubMed 28961700
16. Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P et al. (2018)
    Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
    Rheumatology (Oxford), 57 (2), 370-381
    DOI 10.1093/rheumatology/kex410, PubMed 29207002
17. Reiseter S, Gunnarsson R, Mogens Aaløkken T, Lund MB, Mynarek G, Corander J, Haydon J, Molberg Ø (2018)
    Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study
    Rheumatology (Oxford), 57 (2), 255-262
    DOI 10.1093/rheumatology/kex077, PubMed 28379478
18. Risum K, Hansen BH, Selvaag AM, Molberg Ø, Dagfinrud H, Sanner H (2018)
    Physical activity in patients with oligo- and polyarticular juvenile idiopathic arthritis diagnosed in the era of biologics: a controlled cross-sectional study
    Pediatr Rheumatol Online J, 16 (1), 64
    DOI 10.1186/s12969-018-0281-6, PubMed 30333025
19. Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM (2018)
    Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
    J Am Coll Cardiol, 72 (15), 1804-1813
    DOI 10.1016/j.jacc.2018.07.068, PubMed 30286924
20. Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B (2018)
    Physical Functioning, Pain, and Health-Related Quality of Life in Adults With Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Followup Study
    Arthritis Care Res (Hoboken), 70 (5), 741-749
    DOI 10.1002/acr.23327, PubMed 28732134
21. Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O (2018)
    Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
    Ann Rheum Dis, 77 (9), 1326-1332
    DOI 10.1136/annrheumdis-2018-213201, PubMed 29875097

Publications 2017

1. Andersson H, Kirkhus E, Garen T, Walle-Hansen R, Merckoll E, Molberg Ø (2017)
   Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study
   Arthritis Res Ther, 19 (1), 17
   DOI 10.1186/s13075-017-1219-y, PubMed 28122635
2. Aqrawi LA, Galtung HK, Vestad B, Øvstebø R, Thiede B, Rusthen S, Young A, Guerreiro EM, Utheim TP, Chen X, Utheim ØA, Palm Ø, Jensen JL (2017)
   Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis
   Arthritis Res Ther, 19 (1), 14
   DOI 10.1186/s13075-017-1228-x, PubMed 28122643
3. Augestad L, Hammarstrom C, Flato B, Bjerre A (2017)
   Renal failure of systemic vasculitis in children
   Tidsskr. Nor. Laegeforen., 137 (19), 1507-1511
4. Augestad L, Hammarström C, Flatø B, Bjerre A (2017)
   Renal involvement in paediatric systemic vasculitis
   Tidsskr Nor Laegeforen, 137 (19)
   DOI 10.4045/tidsskr.16.0592, PubMed 29043736
5. Avouac J, Guignabert C, Hoffmann-Vold AM, Ruiz B, Dorfmuller P, Pezet S, Amar O, Tu L, Van Wassenhove J, Sadoine J, Launay D, Elhai M, Cauvet A, Subramaniam A, Resnick R, Hachulla E, Molberg Ø, Kahan A, Humbert M, Allanore Y (2017)
   Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
   Arthritis Rheumatol, 69 (11), 2209-2221
   DOI 10.1002/art.40229, PubMed 28805015
6. Berntsen KS, Tollisen A, Schwartz T, Kirkhus E, Aaløkken TM, Lund MB, Flatø B, Sjaastad I, Sanner H (2017)
   Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement
   J Rheumatol, 44 (6), 827-834
   DOI 10.3899/jrheum.160997, PubMed 28365577
7. Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J et al. (2017)
   An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis
   J Rheumatol, 44 (10), 1453-1457
   DOI 10.3899/jrheum.161369, PubMed 28668810
8. Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA et al. (2017)
   EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
   RMD Open, 3 (2), e000507
   DOI 10.1136/rmdopen-2017-000507, PubMed 29177080
9. Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N et al. (2017)
   Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis
   Arthritis Care Res (Hoboken), 69 (5), 677-686
   DOI 10.1002/acr.23003, PubMed 27564918
10. Götestam Skorpen C, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Koksvik HSS, Jakobsen B, Wallenius M (2017)
    Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus
    Arthritis Care Res (Hoboken), 69 (8), 1201-1208
    DOI 10.1002/acr.23102, PubMed 27696790
11. Gudbrandsson B, Molberg Ø, Palm Ø (2017)
    TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study
    Arthritis Res Ther, 19 (1), 99
    DOI 10.1186/s13075-017-1316-y, PubMed 28521841
12. Gudbrandsson B, Wallenius M, Garen T, Henriksen T, Molberg Ø, Palm Ø (2017)
    Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns
    Arthritis Care Res (Hoboken), 69 (9), 1384-1390
    DOI 10.1002/acr.23146, PubMed 27813289
13. Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W et al. (2017)
    Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
    Ann Rheum Dis, 76 (7), 1207-1218
    DOI 10.1136/annrheumdis-2016-210503, PubMed 28188239
14. Hoffmann-Vold AM, Midtvedt Ø, Tennøe AH, Garen T, Lund MB, Aaløkken TM, Andreassen AK, Elhage F, Brunborg C, Taraldsrud E, Molberg Ø (2017)
    Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
    J Rheumatol, 44 (4), 459-465
    DOI 10.3899/jrheum.160867, PubMed 28089974
15. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA et al. (2017)
    2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
    Arthritis Rheumatol, 69 (12), 2271-2282
    DOI 10.1002/art.40320, PubMed 29106061
16. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA et al. (2017)
    2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
    Ann Rheum Dis, 76 (12), 1955-1964
    DOI 10.1136/annrheumdis-2017-211468, PubMed 29079590
17. Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ et al. (2017)
    Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
    J Pediatr, 189, 72-78.e3
    DOI 10.1016/j.jpeds.2017.06.005, PubMed 28807357
18. Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017)
    Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
    Arthritis Res Ther, 19 (1), 284
    DOI 10.1186/s13075-017-1494-7, PubMed 29268795
19. Roth J, Ravagnani V, Backhaus M, Balint P, Bruns A, Bruyn GA, Collado P, De la Cruz L, Guillaume-Czitrom S, Herlin T, Hernandez C, Iagnocco A, Jousse-Joulin S, Lanni S, Lilleby V, Malattia C, Magni-Manzoni S, Modesto C, Rodriguez A, Nieto JC, Ohrndorf S, Rossi-Semerano L, Selvaag AM, Swen N, Ting TV et al. (2017)
    Preliminary Definitions for the Sonographic Features of Synovitis in Children
    Arthritis Care Res (Hoboken), 69 (8), 1217-1223
    DOI 10.1002/acr.23130, PubMed 27748074
20. Rusthen S, Young A, Herlofson BB, Aqrawi LA, Rykke M, Hove LH, Palm Ø, Jensen JL, Singh PB (2017)
    Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sjögren's syndrome
    Eur J Oral Sci, 125 (4), 265-271
    DOI 10.1111/eos.12358, PubMed 28643390
21. Selvaag AM, Kirkhus E, Törnqvist L, Lilleby V, Aulie HA, Flatø B (2017)
    Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration
    Pediatr Rheumatol Online J, 15 (1), 20
    DOI 10.1186/s12969-017-0151-7, PubMed 28399930
22. Skorpen CG, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Svean Koksvik HS, Jakobsen B, Wallenius M (2017)
    Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study
    Ann Rheum Dis, 77 (2), 264-269
    DOI 10.1136/annrheumdis-2017-211641, PubMed 29092851
23. Tashbayev B, Rusthen S, Young A, Herlofson BB, Hove LH, Singh PB, Rykke M, Aqrawi LA, Chen X, Utheim ØA, Utheim TP, Palm Ø, Jensen JL (2017)
    Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome
    Sci Rep, 7 (1), 10761
    DOI 10.1038/s41598-017-10809-w, PubMed 28883442
24. Volkmann ER, Hoffmann-Vold AM, Chang YL, Jacobs JP, Tillisch K, Mayer EA, Clements PJ, Hov JR, Kummen M, Midtvedt Ø, Lagishetty V, Chang L, Labus JS, Molberg Ø, Braun J (2017)
    Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
    BMJ Open Gastroenterol, 4 (1), e000134
    DOI 10.1136/bmjgast-2017-000134, PubMed 28761687
25. Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM (2017)
    Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II
    Arthritis Rheumatol, 69 (7), 1451-1460
    DOI 10.1002/art.40114, PubMed 28376288

Publications 2016

1. Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, Reed AM, Flatø B (2016)
   Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study
   Scand J Rheumatol, 45 (4), 299-303
   DOI 10.3109/03009742.2015.1126345, PubMed 26854592
2. Andersson H, Aaløkken TM, Günther A, Mynarek GK, Garen T, Lund MB, Molberg Ø (2016)
   Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study
   J Rheumatol, 43 (6), 1107-13
   DOI 10.3899/jrheum.151067, PubMed 27036381
3. Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J et al. (2016)
   A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
   Am J Hum Genet, 100 (1), 64-74
   DOI 10.1016/j.ajhg.2016.11.013, PubMed 28041642
4. Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Jaller Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J et al. (2016)
   Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis
   J Rheumatol, 43 (4), 816-24
   DOI 10.3899/jrheum.150430, PubMed 26932344
5. Elhai M, Avouac J, Hoffmann-Vold AM, Ruzehaji N, Amiar O, Ruiz B, Brahiti H, Ponsoye M, Fréchet M, Burgevin A, Pezet S, Sadoine J, Guilbert T, Nicco C, Akiba H, Heissmeyer V, Subramaniam A, Resnick R, Molberg Ø, Kahan A, Chiocchia G, Allanore Y (2016)
   OX40L blockade protects against inflammation-driven fibrosis
   Proc Natl Acad Sci U S A, 113 (27), E3901-10
   DOI 10.1073/pnas.1523512113, PubMed 27298374
6. Evensen K, Aulie HA, Rønning OM, Flatø B, Russell D (2016)
   Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls
   J Rheumatol, 43 (4), 810-5
   DOI 10.3899/jrheum.150499, PubMed 26879363
7. Finkel TH, Li J, Wei Z, Wang W, Zhang H, Behrens EM, Reuschel EL, Limou S, Wise C, Punaro M, Becker ML, Munro JE, Flatø B, Førre Ø, Thompson SD, Langefeld CD, Glass DN, Glessner JT, Kim CE, Frackelton E, Shivers DK, Thomas KA, Chiavacci RM, Hou C, Xu K et al. (2016)
   Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility
   BMC Med Genet, 17, 24
   DOI 10.1186/s12881-016-0285-3, PubMed 27005825
8. Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
   Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
   Scand J Immunol, 84 (2), 95-9
   DOI 10.1111/sji.12445, PubMed 27135178
9. Gudbrandsson B, Molberg Ø, Garen T, Palm Ø (2016)
   Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway
   Arthritis Care Res (Hoboken), 69 (2), 278-285
   DOI 10.1002/acr.22931, PubMed 27159262
10. Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø (2016)
    Mixed connective tissue disease
    Best Pract Res Clin Rheumatol, 30 (1), 95-111
    DOI 10.1016/j.berh.2016.03.002, PubMed 27421219
11. Hetlevik SO, Flatø B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V (2016)
    Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study
    Ann Rheum Dis, 76 (1), 159-165
    DOI 10.1136/annrheumdis-2016-209522, PubMed 27283334
12. Hoffmann-Vold AM, Tennøe AH, Garen T, Midtvedt Ø, Abraityte A, Aaløkken TM, Lund MB, Brunborg C, Aukrust P, Ueland T, Molberg Ø (2016)
    High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
    Chest, 150 (2), 299-306
    DOI 10.1016/j.chest.2016.03.004, PubMed 26997242
13. Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH (2016)
    Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
    Liver Int, 37 (3), 458-465
    DOI 10.1111/liv.13238, PubMed 27558072
14. Kirkhus E, Gunderson RB, Smith HJ, Flatø B, Hetlevik SO, Larheim TA, Arvidsson LZ (2016)
    Temporomandibular joint involvement in childhood arthritis: comparison of ultrasonography-assessed capsular width and MRI-assessed synovitis
    Dentomaxillofac Radiol, 45 (8), 20160195
    DOI 10.1259/dmfr.20160195, PubMed 27383060
15. López-Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, Freire M, Beltrán E, Narváez J, Alegre-Sancho JJ, Spanish Scleroderma Group, Fernández-Gutiérrez B, Balsa A, Ortiz AM, González-Gay MA, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Witte T, Hunzelmann N, Distler JH, Riekemasten G et al. (2016)
    Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
    Arthritis Rheumatol, 68 (9), 2338-44
    DOI 10.1002/art.39730, PubMed 27111665
16. Palm Ø, Ueland T, Garen T, Michelsen AE, Reiseter S, Aukrust P, Aaløkken TM, Molberg Ø (2016)
    Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome
    Clin Exp Rheumatol, 34 (4), 690-3
    PubMed 27214260
17. Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016)
    Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
    RMD Open, 2 (2), e000291
    DOI 10.1136/rmdopen-2016-000291, PubMed 27752355
18. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2016)
    Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
    J Allergy Clin Immunol, 139 (1), 232-245
    DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878
19. Szodoray P, Stanford SM, Molberg Ø, Munthe LA, Bottini N, Nakken B (2016)
    T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity
    J Allergy Clin Immunol, 138 (3), 839-851.e8
    DOI 10.1016/j.jaci.2016.01.035, PubMed 27056269

Publications 2015

1. Aulie HA, Estensen ME, Selvaag AM, Lilleby V, Murbraech K, Flatø B, Aakhus S (2015)
   Cardiac Function in Adult Patients with Juvenile Idiopathic Arthritis
   J Rheumatol, 42 (9), 1716-23
   DOI 10.3899/jrheum.141351, PubMed 26178287
2. Barth Z, Nomeland Witczak B, Schwartz T, Gjesdal K, Flatø B, Koller A, Sanner H, Sjaastad I (2015)
   In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset
   Rheumatology (Oxford), 55 (3), 535-43
   DOI 10.1093/rheumatology/kev376, PubMed 26500284
3. Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA, Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA et al. (2015)
   A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
   Am J Hum Genet, 96 (4), 565-80
   DOI 10.1016/j.ajhg.2015.02.009, PubMed 25817017
4. Chiaroni-Clarke RC, Li YR, Munro JE, Chavez RA, Scurrah KJ, Pezic A, Akikusa JD, Allen RC, Piper SE, Becker ML, Thompson SD, Lie BA, Flato B, Forre O, Punaro M, Wise C, Saffery R, Finkel TH, Hakonarson H, Ponsonby AL, Ellis JA (2015)
   The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females
   Genes Immun, 16 (7), 495-8
   DOI 10.1038/gene.2015.32, PubMed 26291515
5. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Haroon N, Mulero J et al. (2015)
   Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
   Nat Commun, 6, 7146
   DOI 10.1038/ncomms8146, PubMed 25994336
6. Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg Ø (2015)
   Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
   Semin Arthritis Rheum, 45 (3), 301-8
   DOI 10.1016/j.semarthrit.2015.06.005, PubMed 26190563
7. Gunnarsson R, El-Hage F, Aaløkken TM, Reiseter S, Lund MB, Garen T, Norwegian MCTD study group, Molberg Ø (2015)
   Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease
   Rheumatology (Oxford), 55 (1), 103-8
   DOI 10.1093/rheumatology/kev300, PubMed 26320136
8. Hoffmann-Vold AM (2015)
   Dr. Hoffmann-Vold replies
   J Rheumatol, 42 (12), 2513
   DOI 10.3899/jrheum.150886, PubMed 26628710
9. Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, Gran JT, Molberg Ø (2015)
   Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis
   Arthritis Rheumatol, 67 (8), 2205-12
   DOI 10.1002/art.39166, PubMed 25916462
10. Høyvoll LR, Fløisand Y, Orrem HL, Gunnarsson R, Landrø L, Brevig T, Gaustad P, Nordøy I (2015)
    Hemophagocytic lymphohistiocytosis in leprosy
    Lepr Rev, 86 (4), 403-6
    PubMed 26964439
11. Hoyvoll LR, Floisand Y, Orrem HL, Gunnarsson R, Landro L, Brevig T, Gaustad P, Nordoy I (2015)
    Hemophagocytic lymphohistiocytosis in leprosy
    Lepr. Rev., 86 (4), 403-406
12. Johnsson A, Flatø B, Knudsen PK, Lilleby V (2015)
    Clinical outcome in a Norwegian cohort of patients with chronic recurrent multifocal osteomyelitis
    Scand J Rheumatol, 44 (6), 513-4
    DOI 10.3109/03009742.2015.1055514, PubMed 26312400
13. Kåss A, Hollan I, Fagerland MW, Gulseth HC, Torjesen PA, Førre ØT (2015)
    Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial
    PLoS One, 10 (10), e0139439
    DOI 10.1371/journal.pone.0139439, PubMed 26460564
14. Kirkhus E, Arvidsson LZ, Smith HJ, Flatø B, Hetlevik SO, Larheim TA (2015)
    Disk abnormality coexists with any degree of synovial and osseous abnormality in the temporomandibular joints of children with juvenile idiopathic arthritis
    Pediatr Radiol, 46 (3), 331-41
    DOI 10.1007/s00247-015-3493-7, PubMed 26637998
15. Li YR, Li J, Zhao SD, Bradfield JP, Mentch FD, Maggadottir SM, Hou C, Abrams DJ, Chang D, Gao F, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Glessner JT, Li D, Kao C, Thomas KA, Qiu H, Chiavacci RM, Kim CE, Wang F, Snyder J, Richie MD et al. (2015)
    Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases
    Nat Med, 21 (9), 1018-27
    DOI 10.1038/nm.3933, PubMed 26301688
16. Li YR, Zhao SD, Li J, Bradfield JP, Mohebnasab M, Steel L, Kobie J, Abrams DJ, Mentch FD, Glessner JT, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Li D, Maggadottir SM, Thomas KA, Qui H, Chiavacci RM, Kim CE, Wang F, Snyder J, Flatø B, Førre Ø et al. (2015)
    Genetic sharing and heritability of paediatric age of onset autoimmune diseases
    Nat Commun, 6, 8442
    DOI 10.1038/ncomms9442, PubMed 26450413
17. Reiseter S, Molberg Ø, Gunnarsson R, Lund MB, Aalokken TM, Aukrust P, Ueland T, Garen T, Brunborg C, Michelsen A, Abraityte A, Hoffmann-Vold AM (2015)
    Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
    Arthritis Res Ther, 17, 231
    DOI 10.1186/s13075-015-0756-5, PubMed 26315510
18. Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM, Pachman LM, Reed AM, Rider LG, Cobb J, Platt H, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker J, De Paepe B, Maurer B et al. (2015)
    Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups
    Ann Rheum Dis, 75 (8), 1558-66
    DOI 10.1136/annrheumdis-2015-208119, PubMed 26362759
19. Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B et al. (2015)
    Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
    Lancet, 387 (10019), 671-8
    DOI 10.1016/S0140-6736(15)01021-1, PubMed 26645190
20. Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA, MAINTAIN Nephritis Trial Group (2015)
    Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
    Ann Rheum Dis, 75 (3), 526-31
    DOI 10.1136/annrheumdis-2014-206897, PubMed 25757867

Publications 2014

1. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
   Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
   Ann Rheum Dis, 74 (8), 1515-21
   DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
2. Bergersen TK, Hoffmann-Vold AM, Midtvedt Ø, Gran JT, Mørk C, Toska K, Elstad M (2014)
   Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
   Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
   PubMed 24847906
3. Clarke-Jenssen AC, Mengshoel AM, Strumse YS, Forseth KO (2014)
   Effect of a fibromyalgia rehabilitation programme in warm versus cold climate: a randomized controlled study
   J Rehabil Med, 46 (7), 676-83
   DOI 10.2340/16501977-1819, PubMed 24788929
4. Curran SA, Hollan I, Erridge C, Lappin DF, Murray CA, Sturfelt G, Mikkelsen K, Førre OT, Almdahl SM, Fagerhol MK, Goodyear CS, Riggio MP (2014)
   Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis
   PLoS One, 9 (5), e98627
   DOI 10.1371/journal.pone.0098627, PubMed 24874661
5. Dobloug C, Garen T, Bitter H, Stjärne J, Stenseth G, Grøvle L, Sem M, Gran JT, Molberg Ø (2014)
   Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
   Ann Rheum Dis, 74 (8), 1551-6
   DOI 10.1136/annrheumdis-2013-205127, PubMed 24695011
6. Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjärne J, Grøvle L, Gran JT, Molberg Ø (2014)
   High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
   Eur J Neurol, 22 (4), 672-e41
   DOI 10.1111/ene.12627, PubMed 25530508
7. Ellis JA, Scurrah KJ, Li YR, Ponsonby AL, Chavez RA, Pezic A, Dwyer T, Akikusa JD, Allen RC, Becker ML, Thompson SD, Lie BA, Flatø B, Førre O, Punaro M, Wise C, Finkel TH, Hakonarson H, Munro JE (2014)
   Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis
   J Steroid Biochem Mol Biol, 145, 113-20
   DOI 10.1016/j.jsbmb.2014.10.012, PubMed 25460303
8. Flåm ST, Gunnarsson R, Garen T, Norwegian MCTD Study Group, Lie BA, Molberg Ø (2014)
   The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases
   Rheumatology (Oxford), 54 (3), 528-35
   DOI 10.1093/rheumatology/keu310, PubMed 25187641
9. Haugeberg G, Helgetveit KB, Førre Ø, Garen T, Sommerseth H, Prøven A (2014)
   Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
   BMC Musculoskelet Disord, 15, 289
   DOI 10.1186/1471-2474-15-289, PubMed 25182527
10. Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt Ø, Molberg Ø (2014)
    Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease
    J Rheumatol, 42 (1), 60-3
    DOI 10.3899/jrheum.140047, PubMed 25274890
11. Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B, EC-IBD Study Group (2014)
    Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort
    Scand J Gastroenterol, 50 (3), 300-5
    DOI 10.3109/00365521.2014.991752, PubMed 25535653
12. Lerang K, Gilboe IM, Steinar Thelle D, Gran JT (2014)
    Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study
    Lupus, 23 (14), 1546-52
    DOI 10.1177/0961203314551083, PubMed 25209070
13. Lilleby V, Haydon J, Sanner H, Krossness BK, Ringstad G, Flatø B (2014)
    Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis
    Scand J Rheumatol, 43 (2), 171-3
    DOI 10.3109/03009742.2013.863968, PubMed 24588361
14. Lorentzen AO, Sveberg L, Midtvedt Ø, Kerty E, Heuser K (2014)
    Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice
    Clin Neuropharmacol, 37 (5), 142-8
    DOI 10.1097/WNF.0000000000000047, PubMed 25229171
15. Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R, Spanish GCA Consortium, Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T et al. (2014)
    Influence of the IL17A locus in giant cell arteritis susceptibility
    Ann Rheum Dis, 73 (9), 1742-5
    DOI 10.1136/annrheumdis-2014-205261, PubMed 24919468
16. Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Rodriguez-Rodriguez L, Narváez J, Blanco R, Ortego-Centeno N, Spanish GCA Consortium, Palm O, Diamantopoulos AP, Braun N, Moosig F, Witte T, Beretta L, Lunardi C, Cimmino MA, Vaglio A, Salvarani C, González-Gay MA, Martín J (2014)
    A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA
    PLoS One, 9 (11), e113476
    DOI 10.1371/journal.pone.0113476, PubMed 25409453
17. Midtvedt Ø, Gran JT, Solheim H, Kirkhus E, Spetalen S (2014)
    [Ø. Midtvedt and colleagues reply]
    Tidsskr Nor Laegeforen, 134 (19), 1823
    DOI 10.4045/tidsskr.14.1151, PubMed 25314975
18. Midtvedt Ø, Gran JT, Solheim H, Kirkhus E, Spetalen S (2014)
    [A man in his forties with swelling in both orbits]
    Tidsskr Nor Laegeforen, 134 (15), 1472-6
    DOI 10.4045/tidsskr.13.0115, PubMed 25138406
19. Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H et al. (2014)
    Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients
    Arthritis Rheumatol, 66 (11), 3160-9
    DOI 10.1002/art.38802, PubMed 25077692
20. Mochol M, Berg K, Midtvedt Ø, Ringstad G, Kerty E (2014)
    [Woman with recurrent uveitis and neurological symptoms]
    Tidsskr Nor Laegeforen, 134 (12-13), 1245-8
    DOI 10.4045/tidsskr.13.0433, PubMed 24989204
21. Sanner H, Schwartz T, Flatø B, Vistnes M, Christensen G, Sjaastad I (2014)
    Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage
    PLoS One, 9 (3), e92171
    DOI 10.1371/journal.pone.0092171, PubMed 24647150
22. Sanner H, Sjaastad I, Flatø B (2014)
    Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool
    Rheumatology (Oxford), 53 (9), 1578-85
    DOI 10.1093/rheumatology/keu146, PubMed 24692575
23. Schwartz T, Sjaastad I, Flatø B, Vistnes M, Christensen G, Sanner H (2014)
    In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction
    Rheumatology (Oxford), 53 (12), 2214-22
    DOI 10.1093/rheumatology/keu256, PubMed 24996906
24. Selvaag AM, Aulie HA, Lilleby V, Flatø B (2014)
    Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
    Ann Rheum Dis, 75 (1), 190-5
    DOI 10.1136/annrheumdis-2014-206034, PubMed 25362042

Publications 2013

1. Gudbjornsson B, Ejstrup L, Gran JT, Iversen L, Lindqvist U, Paimela L, Ternowitz T, Ståhle M (2013)
   Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study
   Scand J Rheumatol, 42 (5), 373-8
   DOI 10.3109/03009742.2013.771211, PubMed 23514454
2. Gunnarsson R, Andreassen AK, Molberg Ø, Lexberg ÅS, Time K, Dhainaut AS, Bertelsen LT, Palm Ø, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Garen T, Aaløkken TM, Gilboe IM, Gran JT (2013)
   Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
   Rheumatology (Oxford), 52 (7), 1208-13
   DOI 10.1093/rheumatology/kes430, PubMed 23407386
3. Hjeltnes G, Hollan I, Førre O, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2013)
   Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
   Clin Exp Rheumatol, 31 (3), 415-21
   PubMed 23465067
4. Hoffmann-Vold AM, Molberg Ø, Midtvedt Ø, Garen T, Gran JT (2013)
   Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis
   J Rheumatol, 40 (7), 1127-33
   DOI 10.3899/jrheum.121390, PubMed 23637316
5. International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y et al. (2013)
   Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
   Nat Genet, 45 (7), 730-8
   DOI 10.1038/ng.2667, PubMed 23749187
6. Kåss AS, Førre OT, Fagerland MW, Gulseth HC, Torjesen PA, Hollan I (2013)
   Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
   Scand J Rheumatol, 43 (1), 22-7
   DOI 10.3109/03009742.2013.825007, PubMed 24182325
7. Nitter AK, Forseth KØ (2013)
   Mortality rate and causes of death in women with self-reported musculoskeletal pain: Results from a 17-year follow-up study
   Scand J Pain, 4 (2), 86-92
   DOI 10.1016/j.sjpain.2012.12.002, PubMed 29913892
8. Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I (2013)
   In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity
   Ann Rheum Dis, 73 (10), 1805-10
   DOI 10.1136/annrheumdis-2013-203279, PubMed 23881732
9. Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E, UK GCA Consortium, Spanish GCA Consortium, Braun N et al. (2013)
   Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
   Ann Rheum Dis, 72 (11), 1882-1886
   DOI 10.1136/annrheumdis-2013-203641, PubMed 23946333

Publications 2012

1. Bossini-Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova OY, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, García de la Peña P, Oreiro N, Román-Ivorra JA, Castillo MJ, González-Gay MA, Sáez-Comet L, Castellví I, Schuerwegh AJ, Voskuyl AE, Hoffmann-Vold AM, Hesselstrand R, Nordin A, Lunardi C, Scorza R, van Laar JM et al. (2012)
   Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
   Ann Rheum Dis, 72 (4), 602-7
   DOI 10.1136/annrheumdis-2012-201888, PubMed 22896740
2. Bossini-Castillo L, Simeon CP, Beretta L, Broen JC, Vonk MC, Ríos-Fernández R, Espinosa G, Carreira P, Camps MT, Castillo MJ, González-Gay MA, Beltrán E, Carmen Freire Md, Narváez J, Tolosa C, Witte T, Kreuter A, Schuerwegh AJ, Hoffmann-Vold AM, Hesselstrand R, Lunardi C, van Laar JM, Chee MM, Herrick A, Koeleman BP et al. (2012)
   A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
   Arthritis Res Ther, 14 (2), R85
   DOI 10.1186/ar3809, PubMed 22531499
3. Cénit MC, Simeón CP, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, Blanco FJ, Narvaez J, Tolosa C, Román-Ivorra JA, Gómez-García I, García-Hernández FJ, Gallego M, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P, López-Longo FJ, González-Gay MA, Spanish Scleroderma Group, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ et al. (2012)
   Influence of the IL6 gene in susceptibility to systemic sclerosis
   J Rheumatol, 39 (12), 2294-302
   DOI 10.3899/jrheum.120506, PubMed 23027890
4. Diaz-Gallo LM, Simeon CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MC, Carreira PE, Vargas S, Román-Ivorra JA, González-Gay MA, Tolosa C, López-Longo FJ, Espinosa G, Vicente EF, Hesselstrand R, Riemekasten G, Witte T, Distler JH, Voskuyl AE, Schuerwegh AJ, Shiels PG, Nordin A, Padyukov L, Hoffmann-Vold AM, Scorza R et al. (2012)
   Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
   Ann Rheum Dis, 72 (7), 1233-8
   DOI 10.1136/annrheumdis-2012-202357, PubMed 23172754
5. Dobloug C, Walle-Hansen R, Gran JT, Molberg Ø (2012)
   Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients
   Clin Exp Rheumatol, 30 (6), 838-42
   PubMed 22935197
6. Eike MC, Skinningsrud B, Ronninger M, Stormyr A, Kvien TK, Joner G, Njølstad PR, Førre O, Flatø B, Alfredsson L, Padyukov L, Undlien DE, Lie BA (2012)
   CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations
   Genes Immun, 13 (5), 431-6
   DOI 10.1038/gene.2012.11, PubMed 22513452
7. Gunnarsson R, Aaløkken TM, Molberg Ø, Lund MB, Mynarek GK, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Gran JT (2012)
   Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study
   Ann Rheum Dis, 71 (12), 1966-72
   DOI 10.1136/annrheumdis-2011-201253, PubMed 22550317
8. Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
   Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors
   J Rheumatol, 39 (7), 1341-7
   DOI 10.3899/jrheum.111401, PubMed 22660798
9. Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
   Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients
   Scand J Rheumatol, 41 (3), 240-2
   DOI 10.3109/03009742.2012.656698, PubMed 22401496
10. Hoffmann-Vold AM, Midtvedt Ø, Molberg Ø, Garen T, Gran JT (2012)
    Prevalence of systemic sclerosis in south-east Norway
    Rheumatology (Oxford), 51 (9), 1600-5
    DOI 10.1093/rheumatology/kes076, PubMed 22539477
11. Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT (2012)
    High incidence and prevalence of systemic lupus erythematosus in Norway
    Lupus, 21 (12), 1362-9
    DOI 10.1177/0961203312458168, PubMed 22914817
12. Nitter AK, Pripp AH, Forseth KØ (2012)
    Are sleep problems and non-specific health complaints risk factors for chronic pain? A prospective population-based study with 17 year follow-up
    Scand J Pain, 3 (4), 210-217
    DOI 10.1016/j.sjpain.2012.04.001, PubMed 29913872
13. Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, Gran JT (2012)
    Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data
    Rheumatology (Oxford), 52 (1), 173-9
    DOI 10.1093/rheumatology/kes311, PubMed 23192906
14. Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Fields JZ, Førre ØT (2012)
    Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study
    Clin Rheumatol, 31 (5), 821-7
    DOI 10.1007/s10067-011-1907-y, PubMed 22278161
15. Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B et al. (2012)
    Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
    N Engl J Med, 367 (25), 2396-406
    DOI 10.1056/NEJMoa1205099, PubMed 23252526

Publications 2011

1. Bakland G, Gran JT, Becker-Merok A, Nordvåg BY, Nossent JC (2011)
   Work disability in patients with ankylosing spondylitis in Norway
   J Rheumatol, 38 (3), 479-84
   DOI 10.3899/jrheum.100686, PubMed 21285159
2. Bakland G, Gran JT, Nossent JC (2011)
   Increased mortality in ankylosing spondylitis is related to disease activity
   Ann Rheum Dis, 70 (11), 1921-5
   DOI 10.1136/ard.2011.151191, PubMed 21784726
3. Bossini-Castillo L, Martin JE, Broen J, Gorlova O, Simeón CP, Beretta L, Vonk MC, Callejas JL, Castellví I, Carreira P, García-Hernández FJ, Fernández Castro M, Spanish Scleroderma Group, Coenen MJ, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JH, Koeleman BP, Voskuyl AE, Schuerwegh AJ, Palm Ø, Hesselstrand R, Nordin A et al. (2011)
   A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
   Hum Mol Genet, 21 (4), 926-33
   DOI 10.1093/hmg/ddr522, PubMed 22076442
4. Bossini-Castillo L, Simeon CP, Beretta L, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, Camps MT, Rodríguez-Rodríguez L, Rodríguez-Carballeira M, García-Hernández FJ, López-Longo FJ, Hernández-Hernández V, Sáez-Comet L, Egurbide MV, Hesselstrand R, Nordin A, Hoffmann-Vold AM, Vanthuyne M, Smith V, De Langhe E, Kreuter A, Riemekasten G, Witte T, Hunzelmann N et al. (2011)
   Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population
   Rheumatology (Oxford), 50 (11), 1976-81
   DOI 10.1093/rheumatology/ker259, PubMed 21875883
5. Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Ríos-Fernández R, Espinosa G, Navarrete N, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, García-Hernández FJ, Castellví I, Egurbide MV, Fonollosa V, González-Gay MA, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R et al. (2011)
   Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
   Ann Rheum Dis, 70 (11), 2050-2
   DOI 10.1136/ard.2010.148874, PubMed 21571730
6. Enger TB, Palm Ø, Garen T, Sandvik L, Jensen JL (2011)
   Oral distress in primary Sjögren's syndrome: implications for health-related quality of life
   Eur J Oral Sci, 119 (6), 474-80
   DOI 10.1111/j.1600-0722.2011.00891.x, PubMed 22112034
7. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, van Riel PL, Vanthuyne M, van 't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, González-Gay MA, García-Hernández FJ, González-Escribano MF et al. (2011)
   Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
   PLoS Genet, 7 (7), e1002178
   DOI 10.1371/journal.pgen.1002178, PubMed 21779181
8. Gran JT, Midtvedt Ø, Haug S (2011)
   [A woman with recurrent urticaria, joint pain and fever]
   Tidsskr Nor Laegeforen, 131 (2), 135-6
   DOI 10.4045/tidsskr.10.0354, PubMed 21267032
9. Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Førre O, Almdahl SM, Hollan I (2011)
   Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions
   Rheumatology (Oxford), 51 (4), 679-85
   DOI 10.1093/rheumatology/ker251, PubMed 22157685
10. Gunnarsson R, Molberg O, Gilboe IM, Gran JT, PAHNOR1 Study Group (2011)
    The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients
    Ann Rheum Dis, 70 (6), 1047-51
    DOI 10.1136/ard.2010.143792, PubMed 21398332
11. Haga HJ, Palm O, Peen E (2011)
    Prevalence of IgA class antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease (IBD)
    Clin Rheumatol, 30 (7), 955-7
    DOI 10.1007/s10067-011-1696-3, PubMed 21337132
12. Halvorsen EH, Strønen E, Hammer HB, Goll GL, Sollid LM, Molberg O (2011)
    Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis
    Scand J Immunol, 73 (3), 243-9
    DOI 10.1111/j.1365-3083.2010.02498.x, PubMed 21204897
13. Hjeltnes G, Hollan I, Førre Ø, Wiik A, Mikkelsen K, Agewall S (2011)
    Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
    Scand J Rheumatol, 40 (6), 422-7
    DOI 10.3109/03009742.2011.585350, PubMed 22150462
14. Lerang K, Gilboe IM, Gran JT (2011)
    Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus
    Rheumatology (Oxford), 51 (4), 663-9
    DOI 10.1093/rheumatology/ker318, PubMed 22157467
15. Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
    Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
    Arthritis Rheum, 63 (3), 733-7
    DOI 10.1002/art.30184, PubMed 21360503
16. Nordang GB, Viken MK, Amundsen SS, Sanchez ES, Flatø B, Førre OT, Martin J, Kvien TK, Lie BA (2011)
    Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts
    Rheumatology (Oxford), 51 (4), 619-26
    DOI 10.1093/rheumatology/ker364, PubMed 22179739
17. Pollmann S, Stensland M, Halvorsen EH, Sollid LM, Kvien TK, Fleckenstein B, Molberg O (2011)
    Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate
    Rheumatol Int, 32 (5), 1271-6
    DOI 10.1007/s00296-010-1765-y, PubMed 21267570
18. Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I (2011)
    Cardiac dysfunction in juvenile dermatomyositis: a case-control study
    Ann Rheum Dis, 70 (5), 766-71
    DOI 10.1136/ard.2010.137968, PubMed 21216816
19. Sem M, Lund MB, Molberg O (2011)
    Long-term outcome of lung transplantation in a patient with the anti-synthetase syndrome
    Scand J Rheumatol, 40 (4), 327-8
    DOI 10.3109/03009742.2011.566280, PubMed 21623666
20. Staalesen Strumse YA, Nordvåg BY, Stanghelle JK, Røisland M, Winther A, Pajunen PA, Garen T, Flatø B (2011)
    Efficacy of rehabilitation for patients with ankylosing spondylitis: comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting
    J Rehabil Med, 43 (6), 534-42
    DOI 10.2340/16501977-0804, PubMed 21491073
21. Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D'Cruz D, Gilboe IM, Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA, MAINTAIN Nephritis Trial Group (2011)
    Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial
    Nephrol Dial Transplant, 27 (5), 1924-30
    DOI 10.1093/ndt/gfr553, PubMed 22110048

Publications 2010

1. Arvidsson LZ, Fjeld MG, Smith HJ, Flatø B, Ogaard B, Larheim TA (2010)
   Craniofacial growth disturbance is related to temporomandibular joint abnormality in patients with juvenile idiopathic arthritis, but normal facial profile was also found at the 27-year follow-up
   Scand J Rheumatol, 39 (5), 373-9
   DOI 10.3109/03009741003685624, PubMed 20615158
2. Arvidsson LZ, Smith HJ, Flatø B, Larheim TA (2010)
   Temporomandibular joint findings in adults with long-standing juvenile idiopathic arthritis: CT and MR imaging assessment
   Radiology, 256 (1), 191-200
   DOI 10.1148/radiol.10091810, PubMed 20574096
3. Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y, EUSTAR, Miniati I, Muller A, Iannone F, Distler O, Becvar R, Sierakowsky S, Kowal-Bielecka O, Coelho P, Cabane J, Cutolo M, Shoenfeld Y, Valentini G, Rovensky J, Riemekasten G, Vlachoyiannopoulos P, Caporali R, Jiri S, Inanc M et al. (2010)
   Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
   J Rheumatol, 37 (7), 1488-501
   DOI 10.3899/jrheum.091165, PubMed 20551097
4. Bossini-Castillo L, Broen JC, Simeon CP, Beretta L, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez L, Tolosa C, Román-Ivorra JA, Gómez-Gracia I, García-Hernández FJ, Castellví I, Gallego M, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, de la Peña PG, Pros A et al. (2010)
   A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
   Ann Rheum Dis, 70 (4), 638-41
   DOI 10.1136/ard.2010.141838, PubMed 21187296
5. Breland UM, Hollan I, Saatvedt K, Almdahl SM, Damås JK, Yndestad A, Mikkelsen K, Førre OT, Aukrust P, Ueland T (2010)
   Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
   Rheumatology (Oxford), 49 (6), 1118-27
   DOI 10.1093/rheumatology/keq005, PubMed 20231178
6. Fjeld M, Arvidsson L, Smith HJ, Flatø B, Ogaard B, Larheim T (2010)
   Relationship between disease course in the temporomandibular joints and mandibular growth rotation in patients with juvenile idiopathic arthritis followed from childhood to adulthood
   Pediatr Rheumatol Online J, 8, 13
   DOI 10.1186/1546-0096-8-13, PubMed 20412568
7. Forseth KO, Hafström I, Husby G, Opava C (2010)
   Comprehensive rehabilitation of patients with rheumatic diseases in a warm climate: a literature review
   J Rehabil Med, 42 (10), 897-902
   DOI 10.2340/16501977-0632, PubMed 21031285
8. Gran JT, Midtvedt Ø, Haug S, Aukrust P (2010)
   Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature
   Scand J Rheumatol, 40 (1), 74-9
   DOI 10.3109/03009742.2010.493894, PubMed 20936987
9. Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, MAINTAIN Nephritis Trial Group (2010)
   Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
   Ann Rheum Dis, 69 (12), 2083-9
   DOI 10.1136/ard.2010.131995, PubMed 20833738
10. Kåss AS, Lea TE, Torjesen PA, Gulseth HC, Førre ØT (2010)
    The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study
    Scand J Rheumatol, 39 (2), 109-17
    DOI 10.3109/03009740903270607, PubMed 20337546
11. Lien G, Ueland T, Godang K, Selvaag AM, Førre OT, Flatø B (2010)
    Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study
    Pediatr Rheumatol Online J, 8, 30
    DOI 10.1186/1546-0096-8-30, PubMed 21134287
12. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
    [Lupus-nephritis--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 130 (11), 1140-4
    DOI 10.4045/tidsskr.09.0583, PubMed 20531500
13. Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
    Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
    Ann Rheum Dis, 69 (8), 1484-7
    DOI 10.1136/ard.2009.122796, PubMed 20498208
14. Ostile IL, Johansson I, Aasland A, Flatö B, Möller A (2010)
    Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis
    Scand J Rheumatol, 39 (4), 318-25
    DOI 10.3109/03009740903505213, PubMed 20476866
15. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, van Riel PL, van 't Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, González-Gay MA, González-Escribano MF, Spanish Scleroderma Group, Airo P, van Laar J, Herrick A et al. (2010)
    Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
    Nat Genet, 42 (5), 426-9
    DOI 10.1038/ng.565, PubMed 20383147
16. Ruperto N, Pistorio A, Ravelli A, Rider LG, Pilkington C, Oliveira S, Wulffraat N, Espada G, Garay S, Cuttica R, Hofer M, Quartier P, Melo-Gomes J, Reed AM, Wierzbowska M, Feldman BM, Harjacek M, Huppertz HI, Nielsen S, Flato B, Lahdenne P, Michels H, Murray KJ, Punaro L, Rennebohm R et al. (2010)
    The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis
    Arthritis Care Res (Hoboken), 62 (11), 1533-41
    DOI 10.1002/acr.20280, PubMed 20583105
17. Sanner H, Aaløkken TM, Gran JT, Sjaastad I, Johansen B, Flatø B (2010)
    Pulmonary outcome in juvenile dermatomyositis: a case-control study
    Ann Rheum Dis, 70 (1), 86-91
    DOI 10.1136/ard.2010.131433, PubMed 20805295
18. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
    Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
    Arthritis Care Res (Hoboken), 62 (8), 1103-11
    DOI 10.1002/acr.20203, PubMed 20506141

Publications 2009

1. Aaløkken TM, Lilleby V, Søyseth V, Mynarek G, Pripp AH, Johansen B, Førre O, Kolbenstvedt A (2009)
   Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests
   Acta Radiol, 50 (4), 430-6
   DOI 10.1080/02841850902787677, PubMed 19277918
2. Arvidsson LZ, Flatø B, Larheim TA (2009)
   Radiographic TMJ abnormalities in patients with juvenile idiopathic arthritis followed for 27 years
   Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108 (1), 114-23
   DOI 10.1016/j.tripleo.2009.03.012, PubMed 19540449
3. Flatø B, Lien G, Smerdel-Ramoya A, Vinje O (2009)
   Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis
   J Rheumatol, 36 (3), 642-50
   DOI 10.3899/jrheum.080543, PubMed 19208605
4. Gran JT (2009)
   [A woman with muscle weakness and skin rash]
   Tidsskr Nor Laegeforen, 129 (16), 1648-50
   DOI 10.4045/tidsskr.08.0423, PubMed 19721482
5. Gran JT, Gunnarsson R, Mørk NJ (2009)
   [A man with erythrodermia, muscle weakness and weight loss]
   Tidsskr Nor Laegeforen, 129 (21), 2240-1
   DOI 10.4045/tidsskr.09.0184, PubMed 19898573
6. Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D (2009)
   [Myositis-specific autoantibodies]
   Tidsskr Nor Laegeforen, 129 (16), 1631-4
   DOI 10.4045/tidsskr.09.35501, PubMed 19721478
7. Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT, Helgetveit K, Kvien TK, Lie BA (2009)
   Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand
   Rheumatology (Oxford), 48 (4), 367-70
   DOI 10.1093/rheumatology/ken512, PubMed 19208686
8. Nossent JC, Gran JT (2009)
   Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway
   Scand J Rheumatol, 38 (4), 251-5
   DOI 10.1080/03009740802609558, PubMed 19247847
9. Ostlie IL, Aasland A, Johansson I, Flatö B, Möller A (2009)
   A longitudinal follow-up study of physical and psychosocial health in young adults with chronic childhood arthritis
   Clin Exp Rheumatol, 27 (6), 1039-46
   PubMed 20149328
10. Piechnik SK, Forseth KØ, Krogstad AL (2009)
    Semi-quantitative assessment of the distribution of skin lesions in patients with psoriasis and psoriasis arthritis
    Skin Res Technol, 15 (4), 451-8
    DOI 10.1111/j.1600-0846.2009.00389.x, PubMed 19832957
11. Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Førre ØT (2009)
    Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway. A six-month follow-up study
    Clin Exp Rheumatol, 27 (5 Suppl 56), S46-50
    PubMed 20074439
12. Sanner H, Gran JT, Sjaastad I, Flatø B (2009)
    Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset
    Rheumatology (Oxford), 48 (12), 1541-7
    DOI 10.1093/rheumatology/kep302, PubMed 19776224
13. Sem M, Molberg O, Lund MB, Gran JT (2009)
    Rituximab treatment of the anti-synthetase syndrome: a retrospective case series
    Rheumatology (Oxford), 48 (8), 968-71
    DOI 10.1093/rheumatology/kep157, PubMed 19531628
14. Skinningsrud B, Lie BA, Husebye ES, Kvien TK, Førre Ø, Flatø B, Stormyr A, Joner G, Njølstad PR, Egeland T, Undlien DE (2009)
    A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis
    Ann Rheum Dis, 69 (8), 1471-4
    DOI 10.1136/ard.2009.114934, PubMed 19734133
15. Staalesen Strumse YA, Nordvag BY, Stanghelle JK, Røsland M, Winther A, Pajunen PA, Garen T, Flatø B (2009)
    The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and cold climate
    Scand J Rheumatol, 38 (1), 28-37
    DOI 10.1080/03009740802304549, PubMed 18728936
16. Stensland ME, Pollmann S, Molberg Ø, Sollid LM, Fleckenstein B (2009)
    Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4
    Biol Chem, 390 (2), 99-107
    DOI 10.1515/BC.2009.019, PubMed 19040354